Docket Number:13A-930703
Inventor:Hung Li, Woei-Cherng Shyu, Dah-Ching Ding, Shinn-Zong Lin
IP Status:Issued US7,569,545B2, TW I363,632
Abstract:
This invention is based, at least in part, on the discovery that brain tissue damage can be repaired by administration of granulocyte-colony stimulating factor (G-CSF) and transplantation of mobilized peripheral blood hematopoietic stem cells (PBSCs).
Fields of Application:
The treatment of Parkinson's disease and Chronic stroke.
Advantages when compared to the existing technologies:
Combination of endogenous G-CSF-induced stems cell targeting with autologous exogenous PBSCs transplantation will be an available therapeutic strategy for treating the cerebrovascular disease currently.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you.
